Is patient desperation enough? Philosophy Professor and IPPP Fellow Andrew Peterson assesses the FDA's controversial decision to approve a new Alzheimer's drug

Is patient desperation enough? Philosophy Professor and IPPP Fellow Andrew Peterson assesses the FDA's controversial decision to approve a new Alzheimer's drug